NASDAQ · IAM

Iambic Therapeutics financials

$23.81+25.91%

Close Oct 16, 2026 · split-adjusted

Iambic Therapeutics has no quarterly financial statements on file. Funds and some foreign issuers do not file them.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology